222 related articles for article (PubMed ID: 11992407)
1. Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.
Hoskin DW; Butler JJ; Drapeau D; Haeryfar SM; Blay J
Int J Cancer; 2002 May; 99(3):386-95. PubMed ID: 11992407
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
Greene AL; Makrigiannis AP; Fitzpatrick L; Hoskin DW
J Interferon Cytokine Res; 1997 Dec; 17(12):727-37. PubMed ID: 9452360
[TBL] [Abstract][Full Text] [Related]
3. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.
MacKenzie WM; Hoskin DW; Blay J
Cancer Res; 1994 Jul; 54(13):3521-6. PubMed ID: 8012976
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
Fitzpatrick L; Makrigiannis AP; Kaiser M; Hoskin DW
J Interferon Cytokine Res; 1996 Jul; 16(7):537-46. PubMed ID: 8836920
[TBL] [Abstract][Full Text] [Related]
5. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
7. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells.
Ting CC; Liang SM; Wang J; Chen YY; Hargrove M; Xu N
Biotechnol Ther; 1994-1995; 5(3-4):99-115. PubMed ID: 8608327
[TBL] [Abstract][Full Text] [Related]
8. 2-Chloroadenosine inhibits the MHC-unrestricted cytolytic activity of anti-CD3-activated killer cells: evidence for the involvement of a non-A1/A2 cell-surface adenosine receptor.
Hoskin DW; Reynolds T; Blay J
Cell Immunol; 1994 Nov; 159(1):85-93. PubMed ID: 7954843
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody.
Hoskin DW; Phu T; Makrigiannis AP
Int J Immunopharmacol; 1996 Nov; 18(11):623-31. PubMed ID: 9089006
[TBL] [Abstract][Full Text] [Related]
12. 2-chloroadenosine stimulates granule exocytosis from mouse natural killer cells: evidence for signal transduction through a novel extracellular receptor.
Williams BA; Blay J; Hoskin DW
Exp Cell Res; 1997 May; 233(1):187-97. PubMed ID: 9184087
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
14. Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody.
Zhao C; Morgan M; Haeryfar SM; Blay J; Hoskin DW
Cancer Immunol Immunother; 2003 Mar; 52(3):185-93. PubMed ID: 12649748
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
Ishikawa E; Nakazawa M; Yoshinari M; Minami M
J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
[TBL] [Abstract][Full Text] [Related]
16. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
[TBL] [Abstract][Full Text] [Related]
17. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
Rogachev B; Ziv NY; Mazar J; Nakav S; Chaimovitz C; Zlotnik M; Douvdevani A
Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor activity of anti-CD3-induced activated killer cells.
Yun YS; Hargrove ME; Ting CC
Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
[TBL] [Abstract][Full Text] [Related]
19. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
20. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.
Fishman P; Bar-Yehuda S; Farbstein T; Barer F; Ohana G
J Cell Physiol; 2000 Jun; 183(3):393-8. PubMed ID: 10797314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
